Camilla Macapili Languille is Co-Deputy CEO of Mubadala’s Direct Investments platform, which executes global direct investments with a focus on private equity and actively manages a portfolio targeting growth-oriented companies across a range of sectors, including Healthcare, Consumer, Financial Services, Industrial & Business Services, Energy & Sustainability, and Globalfoundries (semiconductors).Camilla has been with Mubadala Direct Investments since 2013 and has been instrumental in leading the buildout of its Healthcare portfolio and investments team. As the previous Head of Healthcare, Camilla was responsible for executing investments in companies such as PCI Pharma, Envirotainer, Evotec, and Norstella, amongst others, and for building a ~25-person global investments team across Abu Dhabi, New York, London, and Beijing. Prior to launching the Healthcare business, Camilla was responsible for managing the Semiconductors portfolio, overseeing Globalfoundries and leading the monetization of Advanced Micro Devices (AMD). She started her journey in Mubadala overseeing the Utilities and Mining portfolios.Prior to joining Mubadala, Camilla previously worked in M&A for Daiwa Capital and Société Générale based in Paris, as well as in investments for Virgin Group in London, where she managed the Special Situations portfolio and helped to launch Virgin Healthcare. She began her career in Healthcare M&A for JPMorgan in New York and London. Camilla currently serves on the Boards of PCI Pharma, Envirotainer, Va-Q-Tec, and Evotec. She serves as the Co-Chair of Mubadala’s Direct Investments Platform.